Effect of Dietary Lactobacillus casei on Physiometabolic Responses and Liver Histopathology in Common Carp (Cyprinus carpio) After Exposure to Iron Oxide Nanoparticles
- 2021-08-30
- Biological Trace Element Research 200(7)
- S. Hedayati
- Rouhollah Sheikh Veisi
- Seyed Pezhman Hosseini Shekarabi
- Saeid Shahbazi Naserabad
- D. Bagheri
- Hamed Ghafarifarsani
- PubMed: 34458957
- DOI: 10.1007/s12011-021-02906-9
Abstract
A 60-day feeding trial was performed to assess the dietary effect of Lactobacillus casei as a probiotic supplement on some serum biochemical parameters and liver histopathology in common carp fry after exposure to iron oxide nanoparticles (IoNPs). Six treatments were prepared as follows: control (no IoNP exposure and no dietary probiotic), P6: 106 CFU/g probiotic diet, P7: 107 CFU/g probiotic diet, NPs: 0.15 mg/l IoNPs, NPs + P6: 0.15 mg/l IoNPs with 106 CFU/g probiotic diet, and NPs + P7: 0.15 mg/l IoNPs with 107 CFU/gprobiotic diet. Based on the results, serum aspartate aminotransferase and alanine aminotransferase levels were significantly increased in 0.15 mg/l IoNPs, P7, and NPs + P6 treatments compared to the control group. In addition, the examination of antioxidant enzymes showed a significant increase in the levels of cortisol and glutathione S-transferase as well as malondialdehyde level. IoNPs also caused significant histopathological changes in the fish liver during the experiment such as hyperemia in sinusoidal spaces, hepatocytes vacuolation and necrosis, pyknosis, and disruption of hepatic lobules and atrophy. Results revealed the protective effects of dietary L. casei to mitigate the adverse impacts of IoNPs on the physiological processes of common carp.
Keywords: Fe2O3 nanoparticles; Hepatic enzymes; Histopathology; Nanoecotoxicity; Nanomaterials; Probiotic.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lacticaseibacillus casei | Increased Malondialdehyde Levels | Harmful | Moderate |
Lacticaseibacillus casei | Liver Histopathological Damage | Harmful | Large |
Lacticaseibacillus casei | Reduced Adverse Effects of IoNPs | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Increased Liver Enzyme Levels | Harmful | Moderate |
Lacticaseibacillus casei R0215 | Increased Protection Against Iron Oxide Nanoparticles | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Increased Stress Biomarkers | Harmful | Large |
Lacticaseibacillus casei R0215 | Liver Histopathological Damage | Harmful | Large |
Lactobacillus casei | Reduced Adverse Impacts of Iron Oxide Nanoparticles | Beneficial | Moderate |
Lactobacillus casei HA-108 | Mitigated Adverse Impacts of IoNPs on Physiological Processes | Beneficial | Large |
Lactobacillus casei PXN 37 | Elevated Serum Alanine Aminotransferase Levels | Harmful | Moderate |
Lactobacillus casei PXN 37 | Elevated Serum Aspartate Aminotransferase Levels | Harmful | Large |
Lactobacillus casei PXN 37 | Reduced Hepatotoxicity from Iron Oxide Nanoparticles | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Significant Histopathological Changes in Liver | Harmful | Large |
Lactobacillus casei R0215 | Elevated Malondialdehyde Levels | Harmful | Moderate |
Lactobacillus casei R0215 | Elevated Serum Alanine Aminotransferase Levels | Harmful | Moderate |
Lactobacillus casei R0215 | Increased Colonic Mucosal Glutathione S-Transferase Levels | Harmful | Moderate |
Lactobacillus casei R0215 | Increased Cortisol Levels | Harmful | Moderate |
Lactobacillus casei R0215 | Reduced Hepatotoxicity from Iron Oxide Nanoparticles | Beneficial | Moderate |
Lactobacillus casei SD-5213 | Elevated Serum Enzyme Levels | Harmful | Moderate |
Lactobacillus casei SD-5213 | Liver Histopathological Damage | Harmful | Large |
Lactobacillus casei SD-5213 | Reduced Adverse Effects of IoNPs | Beneficial | Moderate |
Lactobacillus casei SD-5842 | Reduced Adverse Physiometabolic Effects | Beneficial | Moderate |
Lactobacillus casei subsp. casei | Elevated Hepatic Enzyme Levels | Harmful | Large |
Lactobacillus casei subsp. casei | Improved Antioxidant Enzyme Levels | Neutral | Moderate |
Lactobacillus casei subsp. casei | Liver Histopathological Damage | Harmful | Large |
Lactobacillus casei subsp. casei | Protection Against Impact of IoNPs | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Mitigated Adverse Physiological Processes | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Reduced Liver Damage | Beneficial | Moderate |
Lactobacillus casei VK4 | Liver Histopathological Damage | Harmful | Large |
Lactobacillus casei VK4 | Reduced Adverse Effects of IoNPs | Beneficial | Moderate |